首页 > 最新文献

Russian Medical Inquiry最新文献

英文 中文
Long-term control of metastatic urothelial carcinoma resistant to platinum-based therapy: clinical case 转移性尿路上皮癌对铂基治疗的长期控制:临床病例
Pub Date : 2023-01-01 DOI: 10.32364/2587-6821-2023-7-6-1
A. S. Shatokhina
Urothelial carcinoma is the most commonly diagnosed malignant tumor of the bladder and/or upper urinary tract. Besides, bladder cancer is a socially significant disease that occupies the 9th place in the oncopathology structure, in which middle-aged and older men mainly become ill. Anticancer therapy of patients with metastatic urothelial cancer in the first line is currently well studied and has its own standards that are actively used in clinical practice. However, the problem of choosing anticancer therapy for patients with metastatic urothelial cancer in the second line is still relevant. Vinflunine therapy is a possible option for the treatment of such patients. The presented clinical case demonstrated long-term control of metastatic urothelial carcinoma in a 67-year-old male patient resistant to platinum-based therapy. The patient received 24 cycles of vinflunine therapy. Hematological toxicity in the form of anemia and grade 1 neutropenia and non-hematological toxicity — grade 2 asthenia, grade 1 myalgia, grade 2 bone pain, which did not require dose reduction or therapy discontinuation, were noted during treatment with vinflunine. Vinflunine therapy provided stabilization of the oncological process and a decrease in the pain syndrome severity, which allowed to refuse taking analgesics. KEYWORDS: metastatic urothelial carcinoma, bladder cancer, inefficacy of platinum-based chemotherapy, second-line therapy, vinflunine, efficacy, safety, life quality. FOR CITATION: Shatokhina A.S. Long-term control of metastatic urothelial carcinoma resistant to platinum-based therapy: clinical case. Russian Medical Inquiry. 2023;7(6) (in Russ.). DOI: 10.32364/2587-6821-2023-7-6-1.
尿路上皮癌是膀胱和/或上尿路最常见的恶性肿瘤。膀胱癌是一种具有社会意义的疾病,在肿瘤病理结构中排名第9位,发病以中老年男性为主。目前,转移性尿路上皮癌一线患者的抗癌治疗研究很好,有自己的标准,并积极应用于临床实践。然而,在二线转移性尿路上皮癌患者选择抗癌治疗的问题仍然是相关的。凡氟宁疗法是治疗此类患者的一种可能选择。该临床病例证明了转移性尿路上皮癌在67岁男性患者中对铂基治疗的长期控制。患者接受了24个周期的长春氟宁治疗。血液学毒性表现为贫血和1级中性粒细胞减少症,非血液学毒性- 2级虚弱,1级肌痛,2级骨痛,不需要减少剂量或停止治疗,在使用vflucine治疗期间被注意到。凡氟宁治疗提供稳定的肿瘤过程和减少疼痛综合征的严重程度,这允许拒绝服用镇痛药。关键词:转移性尿路上皮癌、膀胱癌、铂类化疗无效、二线治疗、长春氟宁、疗效、安全性、生活质量。转移性尿路上皮癌对铂基治疗耐药的长期控制:临床病例。俄罗斯医学调查。2023;7(6)(俄文)。DOI: 10.32364 / 2587-6821-2023-7-6-1。
{"title":"Long-term control of metastatic urothelial carcinoma resistant to platinum-based therapy: clinical case","authors":"A. S. Shatokhina","doi":"10.32364/2587-6821-2023-7-6-1","DOIUrl":"https://doi.org/10.32364/2587-6821-2023-7-6-1","url":null,"abstract":"Urothelial carcinoma is the most commonly diagnosed malignant tumor of the bladder and/or upper urinary tract. Besides, bladder cancer is a socially significant disease that occupies the 9th place in the oncopathology structure, in which middle-aged and older men mainly become ill. Anticancer therapy of patients with metastatic urothelial cancer in the first line is currently well studied and has its own standards that are actively used in clinical practice. However, the problem of choosing anticancer therapy for patients with metastatic urothelial cancer in the second line is still relevant. Vinflunine therapy is a possible option for the treatment of such patients. The presented clinical case demonstrated long-term control of metastatic urothelial carcinoma in a 67-year-old male patient resistant to platinum-based therapy. The patient received 24 cycles of vinflunine therapy. Hematological toxicity in the form of anemia and grade 1 neutropenia and non-hematological toxicity — grade 2 asthenia, grade 1 myalgia, grade 2 bone pain, which did not require dose reduction or therapy discontinuation, were noted during treatment with vinflunine. Vinflunine therapy provided stabilization of the oncological process and a decrease in the pain syndrome severity, which allowed to refuse taking analgesics. KEYWORDS: metastatic urothelial carcinoma, bladder cancer, inefficacy of platinum-based chemotherapy, second-line therapy, vinflunine, efficacy, safety, life quality. FOR CITATION: Shatokhina A.S. Long-term control of metastatic urothelial carcinoma resistant to platinum-based therapy: clinical case. Russian Medical Inquiry. 2023;7(6) (in Russ.). DOI: 10.32364/2587-6821-2023-7-6-1.","PeriodicalId":21378,"journal":{"name":"Russian Medical Inquiry","volume":"38 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79388635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robot-assisted stomach cancer surgery. Technical aspects 机器人辅助胃癌手术。技术方面
Pub Date : 2023-01-01 DOI: 10.32364/2587-6821-2023-7-4-218-224
S. Kovalenko, D. Gladyshev, M. E. Moiseev, V. A. Vetoshkin, V.Yu. Svitich, S. S. Gnedash
Stomach cancer surgery remains one of the most technically challenging areas in abdominal oncology. The frequency of both intra- and postoperative complications is quite high, despite the modern achievements of anesthesiology and the technical support level. Robot-assisted surgical interventions allow to demonstrate all the benefits of minimally invasive technologies for the patient. Additional security is provided by the control of the video system and robotic instruments by one surgeon. The technical features of the robotic complex can be implemented in reducing the frequency of intra- and postoperative complications and improving the quality of surgical intervention, lymphadenectomy, as well as oncological results. The authors present their methodology for conducting surgical interventions in stomach cancer using a robotic surgical complex. Unlike foreign colleagues who use up to seven robotic instruments, the process of performing gastrectomy and subtotal gastrectomy using four robotic instruments has been developed and optimized, which allows to standardize the technique to the extent possible and reduce financial costs. The technique of using indocyanine green with the possibility of visualization in the infrared spectrum of its accumulation in lymph nodes, which are pathways of lymphogenic metastasis, is described. This can improve the accuracy of staging, determine forecast. KEYWORDS: robot-assisted surgery, stomach cancer, oncology, gastric resection, gastrectomy. FOR CITATION: Kovalenko S.A., Gladyshev D.V., Moiseev M.E. et al. Robot-assisted stomach cancer surgery. Technical aspects. Russian Medical Inquiry. 2023;7(4):218–224 (in Russ.). DOI: 10.32364/2587-6821-2023-7-4-218-224.
胃癌手术仍然是腹部肿瘤学中最具技术挑战性的领域之一。尽管麻醉学的现代成就和技术支持水平很高,但手术内和术后并发症的发生率仍然很高。机器人辅助手术干预可以展示微创技术对患者的所有好处。由一名外科医生控制视频系统和机器人设备提供额外的安全性。机器人复合体的技术特点可以在减少手术内和术后并发症的频率,提高手术干预、淋巴结切除和肿瘤结果的质量方面得到实现。作者介绍了他们的方法进行手术干预胃癌使用机器人手术复合体。与国外同行使用多达7台机器人设备不同,使用4台机器人设备进行胃切除术和胃次全切除术的过程已经得到了发展和优化,这使得技术在可能的程度上标准化,并降低了经济成本。本文描述了利用吲哚菁绿在淋巴结中积累的技术,该技术具有在红外光谱中可视化的可能性,这是淋巴源性转移的途径。这样可以提高分期的准确性,确定预报。关键词:机器人辅助手术,胃癌,肿瘤学,胃切除术,胃切除术。引文:Kovalenko S.A, Gladyshev d.v., Moiseev M.E.等。机器人辅助胃癌手术。技术方面。俄罗斯医学调查。2023;7(4):218-224。DOI: 10.32364 / 2587-6821-2023-7-4-218-224。
{"title":"Robot-assisted stomach cancer surgery. Technical aspects","authors":"S. Kovalenko, D. Gladyshev, M. E. Moiseev, V. A. Vetoshkin, V.Yu. Svitich, S. S. Gnedash","doi":"10.32364/2587-6821-2023-7-4-218-224","DOIUrl":"https://doi.org/10.32364/2587-6821-2023-7-4-218-224","url":null,"abstract":"Stomach cancer surgery remains one of the most technically challenging areas in abdominal oncology. The frequency of both intra- and postoperative complications is quite high, despite the modern achievements of anesthesiology and the technical support level. Robot-assisted surgical interventions allow to demonstrate all the benefits of minimally invasive technologies for the patient. Additional security is provided by the control of the video system and robotic instruments by one surgeon. The technical features of the robotic complex can be implemented in reducing the frequency of intra- and postoperative complications and improving the quality of surgical intervention, lymphadenectomy, as well as oncological results. The authors present their methodology for conducting surgical interventions in stomach cancer using a robotic surgical complex. Unlike foreign colleagues who use up to seven robotic instruments, the process of performing gastrectomy and subtotal gastrectomy using four robotic instruments has been developed and optimized, which allows to standardize the technique to the extent possible and reduce financial costs. The technique of using indocyanine green with the possibility of visualization in the infrared spectrum of its accumulation in lymph nodes, which are pathways of lymphogenic metastasis, is described. This can improve the accuracy of staging, determine forecast. KEYWORDS: robot-assisted surgery, stomach cancer, oncology, gastric resection, gastrectomy. FOR CITATION: Kovalenko S.A., Gladyshev D.V., Moiseev M.E. et al. Robot-assisted stomach cancer surgery. Technical aspects. Russian Medical Inquiry. 2023;7(4):218–224 (in Russ.). DOI: 10.32364/2587-6821-2023-7-4-218-224.","PeriodicalId":21378,"journal":{"name":"Russian Medical Inquiry","volume":"50 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75224481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical case of sebaceous gland ectopia in the esophagus — characteristics of endoscopic diagnosis 食管皮脂腺异位1例——内镜诊断特点
Pub Date : 2023-01-01 DOI: 10.32364/2587-6821-2023-7-5-10
V. Lozovaya, O. Gusarova, O. Malikhova, A. Tumanyan
In most of the previously discussed cases, sebaceous gland ectopia (SGE) was described in tissues derived from the ectoderm. Only a small number of publications reported cases of SGE in the esophagus (endoderm organ). The article presents a clinical case of a 68-year-old male patient without complaints from the gastrointestinal tract, however, there were multiple white overlays in the distal esophagus revealed during esophagogastroduodenoscopy. After the morphological examination, the diagnosis of SGE of the esophagus was established. Currently, there is no data in the world literature on the possible malignant transformation of SGE in the esophagus. In an asymptomatic disease course, this group of patients does not need specific drug therapy and/or endoscopic mucosal resection. If there are symptoms of reflux esophagitis, anti-reflux therapy may be prescribed. The main and, most likely, the only possible method of diagnosing this form of neoplasia is endoscopic, accompanied by the mandatory sampling of biopsy material for morphological examination. Conducting a standard EGDS must necessarily include examination using narrow-band imaging or chromoendoscopy of the esophageal mucosa. KEYWORDS: sebaceous gland ectopia, endoscopy, esophagus, narrow-band imaging, esophagogastroduodenoscopy, chromoendoscopy. FOR CITATION: Lozovaya V.V., Gusarova O.A., Malikhova O.A., Tumanyan A.O. Clinical case of sebaceous gland ectopia in the esophagus — characteristics of endoscopic diagnosis. Russian Medical Inquiry. 2023;7(5):318–322 (in Russ.). DOI: 10.32364/2587-6821-2023-7-5-10.
在大多数先前讨论的病例中,皮脂腺异位(SGE)被描述为来自外胚层的组织。只有少数出版物报道了食管(内胚层器官)的SGE病例。本文报告一例68岁男性患者,无胃肠道主诉,但在食管胃十二指肠镜检查时发现食管远端有多发白色覆盖。经形态学检查,确定食管SGE的诊断。目前,世界文献中没有关于食管SGE可能发生恶性转化的资料。在无症状的病程中,这组患者不需要特异性药物治疗和/或内镜下粘膜切除术。如果有反流性食管炎的症状,可以开抗反流治疗。主要的,最有可能的,唯一可能的诊断这种形式的肿瘤的方法是内窥镜,并伴有强制取样活检材料进行形态学检查。进行标准的EGDS必须包括食管粘膜的窄带成像或彩色内镜检查。关键词:皮脂腺异位,内镜,食管,窄带成像,食管胃十二指肠镜,色素内镜。引用本文:Lozovaya v.v., Gusarova o.a., Malikhova o.a., Tumanyan A.O.食道皮脂腺异位的临床病例-内镜诊断的特点。俄罗斯医学调查。2023;7(5):318-322(俄文)。DOI: 10.32364 / 2587-6821-2023-7-5-10。
{"title":"Clinical case of sebaceous gland ectopia in the esophagus — characteristics of endoscopic diagnosis","authors":"V. Lozovaya, O. Gusarova, O. Malikhova, A. Tumanyan","doi":"10.32364/2587-6821-2023-7-5-10","DOIUrl":"https://doi.org/10.32364/2587-6821-2023-7-5-10","url":null,"abstract":"In most of the previously discussed cases, sebaceous gland ectopia (SGE) was described in tissues derived from the ectoderm. Only a small number of publications reported cases of SGE in the esophagus (endoderm organ). The article presents a clinical case of a 68-year-old male patient without complaints from the gastrointestinal tract, however, there were multiple white overlays in the distal esophagus revealed during esophagogastroduodenoscopy. After the morphological examination, the diagnosis of SGE of the esophagus was established. Currently, there is no data in the world literature on the possible malignant transformation of SGE in the esophagus. In an asymptomatic disease course, this group of patients does not need specific drug therapy and/or endoscopic mucosal resection. If there are symptoms of reflux esophagitis, anti-reflux therapy may be prescribed. The main and, most likely, the only possible method of diagnosing this form of neoplasia is endoscopic, accompanied by the mandatory sampling of biopsy material for morphological examination. Conducting a standard EGDS must necessarily include examination using narrow-band imaging or chromoendoscopy of the esophageal mucosa. KEYWORDS: sebaceous gland ectopia, endoscopy, esophagus, narrow-band imaging, esophagogastroduodenoscopy, chromoendoscopy. FOR CITATION: Lozovaya V.V., Gusarova O.A., Malikhova O.A., Tumanyan A.O. Clinical case of sebaceous gland ectopia in the esophagus — characteristics of endoscopic diagnosis. Russian Medical Inquiry. 2023;7(5):318–322 (in Russ.). DOI: 10.32364/2587-6821-2023-7-5-10.","PeriodicalId":21378,"journal":{"name":"Russian Medical Inquiry","volume":"90 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83188303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolic neuroprotection in patient with chronic heart failure: a case report and study results 慢性心力衰竭患者的代谢性神经保护:1例报告和研究结果
Pub Date : 2023-01-01 DOI: 10.32364/2587-6821-2023-7-1-49-55
E. V. Reznik, A. M. Alieva, N. A. Ushakova, E. Krupnova
Cardiovascular diseases (CVD) are the leading cause of global mortality. The relative burden of acute forms of coronary heart disease (CHD) is gradually decreasing in the industrially developed countries, while the prevalence of chronic heart failure (CHF) and the number of hospitalizations of patients with CHF, on the contrary, has demonstrated an upward trend over the last decades. This retrospective analysis was performed to evaluate the data of patients with CHF decompensation. In such patients, cardiogenic encephalopathy (CE) was found in 43.4% of cases. A higher frequency and longer duration of hospitalizations was observed in the group of patients with CE. Also, in patients with CE the mortality rate within two years from the date of index hospitalization was twice as high as in patients without CE. For intensifying the major therapeutic options in the treatment of CHF patients with CE, it is feasible to consider the addition of numerous medications with supplementary pharmacological effects which may potentiate the efficacy of cardiotropic therapy. Among metabolically active drugs, an emphasis should be made on myocardial cytoprotectors. The results of several studies have provided persuasive data supporting the use of cytoprotectors in routine cardiological practice. This article describes a clinical case of using ethylmethylhydroxypyridine succinate for the treatment of an elderly patient with cardiogenic encephalopathy (CE) and presents the data proving the efficacy of this drug as a part of the combined symptomatic and pathogenetic therapy administered to patients with chronic cerebral ischemia amid CHD and CHF. KEYWORDS: cardiovascular diseases, ischemic heart disease, chronic heart failure, cardiogenic encephalopathy, cytoprotection, ethylmethylhydroxypyridine succinate, cardiotropic therapy. FOR CITATION: Reznik E.V., Alieva A.M., Ushakova N.A., Krupnova E.S. Metabolic neuroprotection in patient with chronic heart failure: a case report and study results. Russian Medical Inquiry. 2023;7(1):49–55 (in Russ.). DOI: 10.32364/2587-6821-2023-7-1-49-55.
心血管疾病(CVD)是全球死亡的主要原因。在工业发达国家,急性冠心病(CHD)的相对负担正在逐渐减少,而慢性心力衰竭(CHF)的患病率和CHF患者的住院人数在过去几十年中却呈现上升趋势。本回顾性分析是为了评估CHF失代偿患者的数据。在这些患者中,心源性脑病(CE)发生率为43.4%。在CE患者组中观察到更高的住院频率和更长的住院时间。此外,CE患者自指标住院之日起两年内的死亡率是无CE患者的两倍。为了强化CHF合并CE患者治疗的主要治疗方案,考虑添加多种具有补充药理作用的药物是可行的,这可能会增强促心治疗的疗效。在代谢活性药物中,应重点关注心肌细胞保护剂。几项研究的结果提供了有说服力的数据,支持在常规心脏病实践中使用细胞保护剂。本文描述了一个使用琥珀酸乙基甲基羟吡啶治疗老年心源性脑病(CE)的临床病例,并提供了证明该药物作为慢性脑缺血合并冠心病和CHF患者症状和病理联合治疗的一部分的疗效的数据。关键词:心血管疾病、缺血性心脏病、慢性心力衰竭、心源性脑病、细胞保护、琥珀酸乙基甲基羟吡啶、促心治疗引用本文:Reznik e.v., Alieva a.m., Ushakova n.a., Krupnova E.S.慢性心力衰竭患者的代谢神经保护:一个病例报告和研究结果。俄罗斯医学调查。2023;7(1):49-55(俄文)。DOI: 10.32364 / 2587-6821-2023-7-1-49-55。
{"title":"Metabolic neuroprotection in patient with chronic heart failure: a case report and study results","authors":"E. V. Reznik, A. M. Alieva, N. A. Ushakova, E. Krupnova","doi":"10.32364/2587-6821-2023-7-1-49-55","DOIUrl":"https://doi.org/10.32364/2587-6821-2023-7-1-49-55","url":null,"abstract":"Cardiovascular diseases (CVD) are the leading cause of global mortality. The relative burden of acute forms of coronary heart disease (CHD) is gradually decreasing in the industrially developed countries, while the prevalence of chronic heart failure (CHF) and the number of hospitalizations of patients with CHF, on the contrary, has demonstrated an upward trend over the last decades. This retrospective analysis was performed to evaluate the data of patients with CHF decompensation. In such patients, cardiogenic encephalopathy (CE) was found in 43.4% of cases. A higher frequency and longer duration of hospitalizations was observed in the group of patients with CE. Also, in patients with CE the mortality rate within two years from the date of index hospitalization was twice as high as in patients without CE. For intensifying the major therapeutic options in the treatment of CHF patients with CE, it is feasible to consider the addition of numerous medications with supplementary pharmacological effects which may potentiate the efficacy of cardiotropic therapy. Among metabolically active drugs, an emphasis should be made on myocardial cytoprotectors. The results of several studies have provided persuasive data supporting the use of cytoprotectors in routine cardiological practice. This article describes a clinical case of using ethylmethylhydroxypyridine succinate for the treatment of an elderly patient with cardiogenic encephalopathy (CE) and presents the data proving the efficacy of this drug as a part of the combined symptomatic and pathogenetic therapy administered to patients with chronic cerebral ischemia amid CHD and CHF. KEYWORDS: cardiovascular diseases, ischemic heart disease, chronic heart failure, cardiogenic encephalopathy, cytoprotection, ethylmethylhydroxypyridine succinate, cardiotropic therapy. FOR CITATION: Reznik E.V., Alieva A.M., Ushakova N.A., Krupnova E.S. Metabolic neuroprotection in patient with chronic heart failure: a case report and study results. Russian Medical Inquiry. 2023;7(1):49–55 (in Russ.). DOI: 10.32364/2587-6821-2023-7-1-49-55.","PeriodicalId":21378,"journal":{"name":"Russian Medical Inquiry","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72973160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical tactics optimization for the treatment of patients with relapses of lower limb varicose veins 下肢静脉曲张复发的手术策略优化
Pub Date : 2023-01-01 DOI: 10.32364/2587-6821-2023-7-4-225-231
V. F. Zubritskiy, A. Chernookov, M. R. Kuznetsov, S. Kandyba, S. Dolgov, A. Atayan, A. A. Ramazanov, T. I. Shadyzheva
Aim: to justify the choice of the most optimal treatment method depending on the cause, and clinical and anatomical patterns of the varicose veins relapse. Patients and Methods: treatment results of 157 patients with varicose vein relapses were analyzed. The mean age of patients was 39,8±0,3 years. 3 years after surgery, relapse occurred in 23 (14.7%) patients, in terms of 3 to 5 years — in 95 (60.5%), after 5 years or more — in 39 (24.8%). Different treatment methods were used depending on the individual clinical and anatomical relapse form of varicose veins. Anesthesia choice depended on the type and extent of surgical intervention. Of the open access, 94 (59.9%) surgical interventions were performed, minimally invasive methods of treatment were used in 63 (40.1%) cases. The life quality was assessed at the patient's admission to the clinic and 1–2 years after the end of treatment using the CIVIQ-2 questionnaire. Results and Discussion: after the use of minimally invasive techniques, the average pain intensity on the VAS was 3.1±0.2, in patients who underwent open resurgeries — 5.4±0.3. Early postoperative complications were noted in 3 (1,9%) patients. Long-term treatment results were examined in 129 (82.2%) patients out of 157 included in the study within 12 to 24 months after discharge from the clinic. After performing open surgeries, the average value of the cosmesis index on a ten-point scale was 6.1±0.3 points, after minimally invasive interventions — 7.9±0.5. In the long-term period, the disease repeatedly recurred in 2 (1.6%) patients. It was also found that the use of the developed treatment tactics for patients with relapses of varicose veins leads to an improvement in the life quality parameters by 1,2–1,5 times. Conclusion: eliminating the causes of varicose disease relapse, minimizing the invasiveness of interventions improves immediate and long- term treatment results and the life quality of patients. The use of preoperative duplex angioscanning and modern high-tech treatment methods helps to reduce the relapse number of varicose veins associated with technical and tactical errors of surgeons. KEYWORDS: varicose vein relapses, minimally invasive interventions, open surgeries, life quality. FOR CITATION: Zubritskiy V.F., Chernookov A.I., Kuznetsov M.R. et al. Surgical tactics optimization for the treatment of patients with relapses of lower limb varicose veins. Russian Medical Inquiry. 2023;7(4):225–231 (in Russ.). DOI: 10.32364/2587-6821-2023-7-4-225-231.
目的:根据静脉曲张复发的病因、临床和解剖特点,选择最优的治疗方法。患者与方法:对157例静脉曲张复发患者的治疗结果进行分析。患者平均年龄39.8±0.3岁。术后3年复发23例(14.7%),术后3 - 5年复发95例(60.5%),术后5年及以上复发39例(24.8%)。根据不同的临床和解剖形式的静脉曲张复发,采用不同的治疗方法。麻醉的选择取决于手术干预的类型和程度。开放通路94例(59.9%)行手术干预,63例(40.1%)行微创治疗。采用CIVIQ-2问卷对患者入院及治疗结束后1-2年的生活质量进行评估。结果与讨论:采用微创技术后,VAS平均疼痛强度为3.1±0.2,开腹手术患者疼痛强度为- 5.4±0.3。术后早期并发症3例(1.9%)。在157例纳入研究的患者中,129例(82.2%)在出院后12 - 24个月内检查了长期治疗结果。开腹手术后10分制美容指数平均值为6.1±0.3分,微创手术后美容指数平均值为- 7.9±0.5分。长期反复复发2例(1.6%)。研究还发现,静脉曲张复发患者采用先进的治疗策略,其生活质量参数提高了1,2 - 1,5倍。结论:消除了静脉曲张疾病复发的原因,减少了干预措施的侵入性,提高了近期和远期的治疗效果和患者的生活质量。术前双重血管扫描和现代高科技治疗方法的使用有助于减少因外科医生的技术和战术错误而导致的静脉曲张复发率。关键词:静脉曲张复发,微创干预,开放性手术,生活质量。引证:Zubritskiy V.F, Chernookov a.i., Kuznetsov M.R.等。下肢静脉曲张复发的手术策略优化。俄罗斯医学调查。2023;7(4):225-231(俄语)。DOI: 10.32364 / 2587-6821-2023-7-4-225-231。
{"title":"Surgical tactics optimization for the treatment of patients with relapses of lower limb varicose veins","authors":"V. F. Zubritskiy, A. Chernookov, M. R. Kuznetsov, S. Kandyba, S. Dolgov, A. Atayan, A. A. Ramazanov, T. I. Shadyzheva","doi":"10.32364/2587-6821-2023-7-4-225-231","DOIUrl":"https://doi.org/10.32364/2587-6821-2023-7-4-225-231","url":null,"abstract":"Aim: to justify the choice of the most optimal treatment method depending on the cause, and clinical and anatomical patterns of the varicose veins relapse. Patients and Methods: treatment results of 157 patients with varicose vein relapses were analyzed. The mean age of patients was 39,8±0,3 years. 3 years after surgery, relapse occurred in 23 (14.7%) patients, in terms of 3 to 5 years — in 95 (60.5%), after 5 years or more — in 39 (24.8%). Different treatment methods were used depending on the individual clinical and anatomical relapse form of varicose veins. Anesthesia choice depended on the type and extent of surgical intervention. Of the open access, 94 (59.9%) surgical interventions were performed, minimally invasive methods of treatment were used in 63 (40.1%) cases. The life quality was assessed at the patient's admission to the clinic and 1–2 years after the end of treatment using the CIVIQ-2 questionnaire. Results and Discussion: after the use of minimally invasive techniques, the average pain intensity on the VAS was 3.1±0.2, in patients who underwent open resurgeries — 5.4±0.3. Early postoperative complications were noted in 3 (1,9%) patients. Long-term treatment results were examined in 129 (82.2%) patients out of 157 included in the study within 12 to 24 months after discharge from the clinic. After performing open surgeries, the average value of the cosmesis index on a ten-point scale was 6.1±0.3 points, after minimally invasive interventions — 7.9±0.5. In the long-term period, the disease repeatedly recurred in 2 (1.6%) patients. It was also found that the use of the developed treatment tactics for patients with relapses of varicose veins leads to an improvement in the life quality parameters by 1,2–1,5 times. Conclusion: eliminating the causes of varicose disease relapse, minimizing the invasiveness of interventions improves immediate and long- term treatment results and the life quality of patients. The use of preoperative duplex angioscanning and modern high-tech treatment methods helps to reduce the relapse number of varicose veins associated with technical and tactical errors of surgeons. KEYWORDS: varicose vein relapses, minimally invasive interventions, open surgeries, life quality. FOR CITATION: Zubritskiy V.F., Chernookov A.I., Kuznetsov M.R. et al. Surgical tactics optimization for the treatment of patients with relapses of lower limb varicose veins. Russian Medical Inquiry. 2023;7(4):225–231 (in Russ.). DOI: 10.32364/2587-6821-2023-7-4-225-231.","PeriodicalId":21378,"journal":{"name":"Russian Medical Inquiry","volume":"6 3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83424182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prokinetics: the role in the therapy of a patient with GERD 原动力学:在反流患者治疗中的作用
Pub Date : 2023-01-01 DOI: 10.32364/2587-6821-2023-7-5-6
M. Livzan, D. S. Bordin, O. Gaus, M.A. Lisovsky
One of the most common pathologies in the structure of digestive diseases is gastroesophageal reflux disease (GERD), which is associated with low life quality of patients, while in insufficient disease control — with an increased risk of Barrett's esophagus and, as a consequence, adenocarcinoma. In accordance with the relevant consensus papers, in particular, the Lyon Consensus, a key factor in the GERD pathogenesis is a persistent disorder of the upper digestive tract motility with the formation of pathological gastric reflux (in some cases, duodenum) contents into the esophagus, which determines the expediency of including prokinetics in the treatment regimen of the disease. This article provides information about the main risk factors and mechanisms of the pathological reflux in GERD, the frequency and duration of which determine the risk and progression of the disease. Special attention is paid to the modern methods for the correction of esophageal and gastric motor disorders, including the role of prokinetics in the patient's therapy. KEYWORDS: prokinetics, gastroesophageal reflux disease, functional dyspepsia, itopride hydrochloride. FOR CITATION: Livzan M.A., Bordin D.S., Gaus O.V., Lisovsky M.A. Prokinetics: the role in the therapy of a patient with GERD. Russian Medical Inquiry. 2023;7(5):283–291 (in Russ.). DOI: 10.32364/2587-6821-2023-7-5-6.
消化系统疾病结构中最常见的病理之一是胃食管反流病(GERD),它与患者的生活质量低有关,而疾病控制不足-增加巴雷特食管的风险,并因此增加腺癌的风险。根据相关共识论文,特别是里昂共识,GERD发病的一个关键因素是上消化道运动持续紊乱,形成病理性胃反流(在某些情况下是十二指肠)内容物进入食管,这决定了将促动力学纳入该疾病的治疗方案的便利性。本文提供了有关GERD中病理性反流的主要危险因素和机制的信息,其频率和持续时间决定了疾病的风险和进展。特别注意的是现代方法的纠正食道和胃运动障碍,包括促动力学的作用在病人的治疗。关键词:促动力学,胃食管反流病,功能性消化不良,盐酸依托必利引文:Livzan M.A., Bordin d.s., Gaus o.v., liisovsky M.A.。促动力学:在反流患者治疗中的作用。俄罗斯医学调查。2023;7(5):283-291。DOI: 10.32364 / 2587-6821-2023-7-5-6。
{"title":"Prokinetics: the role in the therapy of a patient with GERD","authors":"M. Livzan, D. S. Bordin, O. Gaus, M.A. Lisovsky","doi":"10.32364/2587-6821-2023-7-5-6","DOIUrl":"https://doi.org/10.32364/2587-6821-2023-7-5-6","url":null,"abstract":"One of the most common pathologies in the structure of digestive diseases is gastroesophageal reflux disease (GERD), which is associated with low life quality of patients, while in insufficient disease control — with an increased risk of Barrett's esophagus and, as a consequence, adenocarcinoma. In accordance with the relevant consensus papers, in particular, the Lyon Consensus, a key factor in the GERD pathogenesis is a persistent disorder of the upper digestive tract motility with the formation of pathological gastric reflux (in some cases, duodenum) contents into the esophagus, which determines the expediency of including prokinetics in the treatment regimen of the disease. This article provides information about the main risk factors and mechanisms of the pathological reflux in GERD, the frequency and duration of which determine the risk and progression of the disease. Special attention is paid to the modern methods for the correction of esophageal and gastric motor disorders, including the role of prokinetics in the patient's therapy. KEYWORDS: prokinetics, gastroesophageal reflux disease, functional dyspepsia, itopride hydrochloride. FOR CITATION: Livzan M.A., Bordin D.S., Gaus O.V., Lisovsky M.A. Prokinetics: the role in the therapy of a patient with GERD. Russian Medical Inquiry. 2023;7(5):283–291 (in Russ.). DOI: 10.32364/2587-6821-2023-7-5-6.","PeriodicalId":21378,"journal":{"name":"Russian Medical Inquiry","volume":"266 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86349887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Histione of the intestinal epithelial barrier in inflammatory bowel diseases: morphofunctional characteristics and clinical significance 炎症性肠病中肠上皮屏障的组蛋白:形态功能特征及临床意义
Pub Date : 2023-01-01 DOI: 10.32364/2587-6821-2023-7-5-7
M. I. Skalinskaya, R. Deev, E. V. Presnyakov, I. Chekmareva, E. Skazyvaeva, I. Bakulin
From the modern standpoint of theoretical histology, the term "histione" is commonly understood to mean a temporary or permanent cellular association, whose combined functional activity is aimed at achieving significant structural and other types of homeostasis. The model concept of histione can be successfully applied to analyze the structure, function and their disorders, including characterizing the so- called intestinal epithelial barrier. The available scientific data indicate the involvement of increased intestinal permeability syndrome in the pathomorphogenesis of a number of diseases, including ulcerative colitis and Crohn's disease, related to inflammatory bowel diseases (IBD), which makes the problem of regulating the intestinal barrier permeability one of the most urgent for pathologists and clinicians. The article combines and organizes ideas about the histione of the intestinal epithelial barrier, the patterns of its regulation mechanisms in patients with IBD, as well as methods for assessing intestinal permeability in this patient cohort. KEYWORDS: histione, intestinal epithelial barrier, increased intestinal permeability, Crohn's disease, ulcerative colitis, inflammatory bowel diseases. FOR CITATION: Skalinskaya M.I., Deev R.V., Presnyakov E.V., Chekmareva I.A., Skazyvaeva E.V., Bakulin I.G. Histione of the intestinal epithelial barrier in inflammatory bowel diseases: morphofunctional characteristics and clinical significance. Russian Medical Inquiry. 2023;7(5):292–299 (in Russ.). DOI: 10.32364/2587-6821-2023-7-5-7.
从理论组织学的现代观点来看,术语“组蛋白”通常被理解为指暂时或永久的细胞结合,其综合功能活动旨在实现重要的结构和其他类型的内稳态。组蛋白的模型概念可以成功地应用于分析肠上皮屏障的结构、功能及其紊乱,包括表征肠上皮屏障。现有的科学数据表明,肠通透性增加综合征参与了与炎症性肠病(IBD)相关的许多疾病的病理形态学发生,包括溃疡性结肠炎和克罗恩病,这使得调节肠屏障通透性成为病理学家和临床医生最紧迫的问题之一。本文结合并整理了IBD患者肠上皮屏障的组蛋白及其调节机制的模式,以及该患者队列中肠通透性的评估方法。关键词:组蛋白、肠上皮屏障、肠通透性增加、克罗恩病、溃疡性结肠炎、炎症性肠病引用本文:Skalinskaya M.I., Deev r.v., Presnyakov e.v., Chekmareva i.a., Skazyvaeva e.v., Bakulin I.G.炎症性肠病肠上皮屏障的组织蛋白:形态功能特征和临床意义。俄罗斯医学调查。2023;7(5):292-299(俄文)。DOI: 10.32364 / 2587-6821-2023-7-5-7。
{"title":"Histione of the intestinal epithelial barrier in inflammatory bowel diseases: morphofunctional characteristics and clinical significance","authors":"M. I. Skalinskaya, R. Deev, E. V. Presnyakov, I. Chekmareva, E. Skazyvaeva, I. Bakulin","doi":"10.32364/2587-6821-2023-7-5-7","DOIUrl":"https://doi.org/10.32364/2587-6821-2023-7-5-7","url":null,"abstract":"From the modern standpoint of theoretical histology, the term \"histione\" is commonly understood to mean a temporary or permanent cellular association, whose combined functional activity is aimed at achieving significant structural and other types of homeostasis. The model concept of histione can be successfully applied to analyze the structure, function and their disorders, including characterizing the so- called intestinal epithelial barrier. The available scientific data indicate the involvement of increased intestinal permeability syndrome in the pathomorphogenesis of a number of diseases, including ulcerative colitis and Crohn's disease, related to inflammatory bowel diseases (IBD), which makes the problem of regulating the intestinal barrier permeability one of the most urgent for pathologists and clinicians. The article combines and organizes ideas about the histione of the intestinal epithelial barrier, the patterns of its regulation mechanisms in patients with IBD, as well as methods for assessing intestinal permeability in this patient cohort. KEYWORDS: histione, intestinal epithelial barrier, increased intestinal permeability, Crohn's disease, ulcerative colitis, inflammatory bowel diseases. FOR CITATION: Skalinskaya M.I., Deev R.V., Presnyakov E.V., Chekmareva I.A., Skazyvaeva E.V., Bakulin I.G. Histione of the intestinal epithelial barrier in inflammatory bowel diseases: morphofunctional characteristics and clinical significance. Russian Medical Inquiry. 2023;7(5):292–299 (in Russ.). DOI: 10.32364/2587-6821-2023-7-5-7.","PeriodicalId":21378,"journal":{"name":"Russian Medical Inquiry","volume":"209 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90072155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The clinical course of chronic rhinosinusitis with sinonasal polyposis in patients with eosinophilic asthma amid the treatment 慢性鼻窦炎合并鼻息肉病合并嗜酸性哮喘患者治疗期间的临床病程
Pub Date : 2023-01-01 DOI: 10.32364/2587-6821-2023-7-2-103-109
N. Boyko, E. Churyukina, O. Lodochkina, O. Ukhanova
Background: chronic rhinosinusitis (CRS) with polyps is associated with eosinophilic inflammation where interleukin-5 (IL-5) is acting as a key mediator. Commonly, CRS co-exists with asthma. Aim: to assess the efficacy of reslizumab for the treatment of CRS with sinonasal polyposis in patients with severe eosinophilic asthma. Patients and Methods: the study included 21 patients. For the management of severe asthma all patients received reslizumab as intravenous infusion at a dose of 3 mg/kg body weight, once every 4 weeks. CRS with sinonasal polyposis was found in 19 patients, pathological changes of the paranasal sinuses revealed by computer tomography (CT) — in all patients, and symptoms of chronic non-allergic rhinitis with eosinophilia syndrome (NARES) were present in 2 patients. The efficacy of therapy was evaluated 6 months after the beginning of treatment. Over-time changes in the following indicators were evaluated: nasal symptoms, endoscopic pattern of the nasal cavity and paranasal sinuses, total polyp score (TPS), CT findings in the paranasal sinuses, rhinocytogram, blood eosinophil cationic protein level, and eosinophilia. The effectiveness of asthma control was assessed by the reduction in asthma exacerbation rate and the requirements for systemic corticosteroids, as well as the spirometry results and the asthma control test. Results: along with a noticeable improvement of asthma control, 20 patients had clinical, endoscopic and radiological signs of the decrease in severity of nasal symptoms. A more significant improvement of asthma control was achieved in patients with CRS and polyps. The medical histories of patients with CRS and polyps demonstrated that at the early stages of the disease they had NARES symptoms. This finding suggests that NARES could be a predictor of eosinophilic non-IgE-mediated asthma and nasal polyps. Conclusion: the use of reslizumab for the treatment patients with eosinophilic asthma and comorbid CRS with polyps and NARES enables not only to improve the control of asthma symptoms but also to achieve the notable regression of nasal symptoms. KEYWORDS: chronic rhinosinusitis with polyps, asthma, iterleukin-5, reslizumab, non-allergic rhinitis with eosinophilia syndrome. FOR CITATION: Boyko N.V., Churyukina E.V., Lodochkina O.E., Ukhanova O.P. The clinical course of chronic rhinosinusitis with sinonasal polyposis in patients with eosinophilic asthma amid the treatment. Russian Medical Inquiry. 2023;7(2):103–109 (in Russ.). DOI: 10.32364/2587-6821-2023-7-2-103-109.
背景:慢性鼻窦炎(CRS)伴息肉与嗜酸性粒细胞炎症相关,其中白细胞介素-5 (IL-5)是关键的介质。CRS通常与哮喘共存。目的:评价瑞珠单抗治疗CRS合并重度嗜酸性哮喘患者鼻窦息肉病的疗效。患者和方法:本研究纳入21例患者。对于严重哮喘的治疗,所有患者均接受瑞珠单抗静脉输注,剂量为3mg /kg体重,每4周1次。CRS合并鼻窦息肉病19例,所有患者CT表现为鼻窦病变,2例出现慢性非变应性鼻炎伴嗜酸性粒细胞增多综合征(NARES)症状。治疗开始6个月后评价疗效。评估以下指标随时间的变化:鼻症状、鼻腔和鼻窦内镜模式、息肉总评分(TPS)、鼻窦CT表现、鼻细胞图、血嗜酸性粒细胞阳离子蛋白水平和嗜酸性粒细胞增多。通过哮喘发作率的降低、全体性糖皮质激素的需要量、肺活量测定结果和哮喘控制试验来评估哮喘控制的有效性。结果:随着哮喘控制的显著改善,20例患者有临床、内镜和放射学迹象表明鼻症状严重程度减轻。CRS合并息肉患者的哮喘控制改善更为显著。CRS和息肉患者的病史表明,在疾病的早期阶段,他们有NARES症状。这一发现提示NARES可能是嗜酸性非ige介导的哮喘和鼻息肉的预测因子。结论:瑞利珠单抗治疗嗜酸性粒细胞性哮喘合并CRS合并息肉、NARES患者,不仅哮喘症状得到改善控制,而且鼻部症状明显消退。关键词:慢性鼻窦炎伴息肉、哮喘、白介素-5、reslizumab、非变应性鼻炎伴嗜酸性粒细胞增多综合征引用本文:Boyko n.v., Churyukina e.v., Lodochkina o.e., Ukhanova O.P.。慢性鼻窦炎合并嗜酸性哮喘患者鼻息肉病治疗的临床过程。俄罗斯医学调查。2023;7(2):103-109。DOI: 10.32364 / 2587-6821-2023-7-2-103-109。
{"title":"The clinical course of chronic rhinosinusitis with sinonasal polyposis in patients with eosinophilic asthma amid the treatment","authors":"N. Boyko, E. Churyukina, O. Lodochkina, O. Ukhanova","doi":"10.32364/2587-6821-2023-7-2-103-109","DOIUrl":"https://doi.org/10.32364/2587-6821-2023-7-2-103-109","url":null,"abstract":"Background: chronic rhinosinusitis (CRS) with polyps is associated with eosinophilic inflammation where interleukin-5 (IL-5) is acting as a key mediator. Commonly, CRS co-exists with asthma. Aim: to assess the efficacy of reslizumab for the treatment of CRS with sinonasal polyposis in patients with severe eosinophilic asthma. Patients and Methods: the study included 21 patients. For the management of severe asthma all patients received reslizumab as intravenous infusion at a dose of 3 mg/kg body weight, once every 4 weeks. CRS with sinonasal polyposis was found in 19 patients, pathological changes of the paranasal sinuses revealed by computer tomography (CT) — in all patients, and symptoms of chronic non-allergic rhinitis with eosinophilia syndrome (NARES) were present in 2 patients. The efficacy of therapy was evaluated 6 months after the beginning of treatment. Over-time changes in the following indicators were evaluated: nasal symptoms, endoscopic pattern of the nasal cavity and paranasal sinuses, total polyp score (TPS), CT findings in the paranasal sinuses, rhinocytogram, blood eosinophil cationic protein level, and eosinophilia. The effectiveness of asthma control was assessed by the reduction in asthma exacerbation rate and the requirements for systemic corticosteroids, as well as the spirometry results and the asthma control test. Results: along with a noticeable improvement of asthma control, 20 patients had clinical, endoscopic and radiological signs of the decrease in severity of nasal symptoms. A more significant improvement of asthma control was achieved in patients with CRS and polyps. The medical histories of patients with CRS and polyps demonstrated that at the early stages of the disease they had NARES symptoms. This finding suggests that NARES could be a predictor of eosinophilic non-IgE-mediated asthma and nasal polyps. Conclusion: the use of reslizumab for the treatment patients with eosinophilic asthma and comorbid CRS with polyps and NARES enables not only to improve the control of asthma symptoms but also to achieve the notable regression of nasal symptoms. KEYWORDS: chronic rhinosinusitis with polyps, asthma, iterleukin-5, reslizumab, non-allergic rhinitis with eosinophilia syndrome. FOR CITATION: Boyko N.V., Churyukina E.V., Lodochkina O.E., Ukhanova O.P. The clinical course of chronic rhinosinusitis with sinonasal polyposis in patients with eosinophilic asthma amid the treatment. Russian Medical Inquiry. 2023;7(2):103–109 (in Russ.). DOI: 10.32364/2587-6821-2023-7-2-103-109.","PeriodicalId":21378,"journal":{"name":"Russian Medical Inquiry","volume":"76 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83874308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of the genes of the natriuretic peptide and antioxidant defense systems in creating the risk of myocardial infarction development (the preliminary results of a pilot study) 利钠肽基因和抗氧化防御系统在造成心肌梗死发展风险中的作用(初步研究的初步结果)
Pub Date : 2023-01-01 DOI: 10.32364/2587-6821-2023-7-1-5-12
M. Khutornaya, O. Khryachkova, A. Sinitskaya, A.O. Poddubnya, A. Ponasenko, V. Kashtalap
Aim: to reveal a relationship of single-nucleotide polymorphic variants of the genes of the natriuretic peptides, antioxidant defense systems and the endothelial function with the development of myocardial infarction. Patients and Methods: the study included 146 patients with myocardial infarction (MI) and maintained or moderately decreased left ventricular ejection fraction: 108 males and 38 females with a mean age of 57 (51; 64) years. The control group was composed of Kemerovo city residents without acute MI (n=300, 190 females and 110 males). To make the evaluation, genomic DNA was isolated from the peripheral blood by phenol- chloroform extraction according to the standard protocol. Real-time PCR method was used for genotyping. To conduct the study, 24 polymorphic variants of 14 genes (those of the natriuretic peptides, antioxidant defense systems and the endothelial function) were selected. Results: significant associations with the allelic variants of CBR1 and CBR3 genes (carbonyl reductase 1 and 3 genes) of the antioxidant defense system were found in the sample of studied patients with MI (not divided by gender or age). When the patients were divided by gender, the following associations were found: in males the single-nucleotide polymorphic variant (SNPV) genotypes CBR1 rs9024 and CBR3 rs1056892 had the protective effect against susceptibility to myocardial infarction (dominant inheritance pattern). It was demonstrated that allelic variants in the NPR2 gene (the gene of atrial natriuretic peptide receptor 2) comprised a risk factor for MI development. In females, a relationship between the assessed genetic factors and the MI development (dominant inheritance pattern) could be associated with SNPV genotypes NPR2 rs13288085 and rs7034957, CBR1 rs9024, and CBR3 rs1056892 which are characterized by the protective effect. Conclusion: some polymorphic variants of the genes of the natriuretic peptide and antioxidant defense systems are associated with the risk and the protective effect against MI susceptibility. The preliminary findings indicate that it is necessary to continue investigations of the identified single-nucleotide polymorphic variants and to assess their impact on the MI severity and the risk of recurrent cardiovascular events in the long-term perspective. KEYWORDS: myocardial infarction, gene, natriuretic peptides, antioxidant defense, polymorphic variants. FOR CITATION: Khutornaya M.V., Khryachkova O.N., Sinitskaya A.V. et al. Role of the genes of the natriuretic peptide and antioxidant defense systems in creating the risk of myocardial infarction development (the preliminary results of a pilot study). Russian Medical Inquiry. 2023;7(1):5–12 (in Russ.). DOI: 10.32364/2587-6821-2023-7-1-5-12.
目的:探讨利钠肽基因单核苷酸多态性变异、抗氧化防御系统和内皮功能与心肌梗死发生发展的关系。患者和方法:该研究纳入146例心肌梗死(MI)患者,左室射血分数维持或中度降低:男性108例,女性38例,平均年龄57岁(51岁;64)年。对照组为无急性心肌梗死的克麦罗沃市居民300人,其中女性190人,男性110人。为了进行评价,根据标准方案,采用苯酚-氯仿萃取法从外周血中分离基因组DNA。采用实时荧光定量PCR法进行基因分型。为了进行研究,我们选择了14个基因(利钠肽、抗氧化防御系统和内皮功能基因)的24个多态性变异。结果:在研究的心肌梗死患者样本中发现与抗氧化防御系统CBR1和CBR3基因(羰基还原酶1和3基因)的等位基因变异有显著关联(未按性别或年龄划分)。当患者按性别划分时,发现以下关联:在男性中,单核苷酸多态性变异(SNPV)基因型CBR1 rs9024和CBR3 rs1056892对心肌梗死易感性具有保护作用(显性遗传模式)。研究表明,NPR2基因(心房利钠肽受体2基因)的等位基因变异是心肌梗死发生的一个危险因素。在女性中,被评估的遗传因素与MI发育(显性遗传模式)之间的关系可能与SNPV基因型NPR2 rs13288085和rs7034957、CBR1 rs9024和CBR3 rs1056892相关,这些基因型具有保护作用。结论:利钠肽和抗氧化防御系统基因的一些多态性变异与心肌梗死易感性的风险和保护作用有关。初步研究结果表明,有必要继续研究已确定的单核苷酸多态性变异,并从长远角度评估其对心肌梗死严重程度和心血管事件复发风险的影响。关键词:心肌梗死,基因,利钠肽,抗氧化防御,多态变异。引证:Khutornaya M.V, Khryachkova O.N, Sinitskaya A.V.等。利钠肽基因和抗氧化防御系统在造成心肌梗死发展风险中的作用(初步研究的初步结果)。俄罗斯医学调查。2023;7(1):5-12(俄文)。DOI: 10.32364 / 2587-6821-2023-7-1-5-12。
{"title":"Role of the genes of the natriuretic peptide and antioxidant defense systems in creating the risk of myocardial infarction development (the preliminary results of a pilot study)","authors":"M. Khutornaya, O. Khryachkova, A. Sinitskaya, A.O. Poddubnya, A. Ponasenko, V. Kashtalap","doi":"10.32364/2587-6821-2023-7-1-5-12","DOIUrl":"https://doi.org/10.32364/2587-6821-2023-7-1-5-12","url":null,"abstract":"Aim: to reveal a relationship of single-nucleotide polymorphic variants of the genes of the natriuretic peptides, antioxidant defense systems and the endothelial function with the development of myocardial infarction. Patients and Methods: the study included 146 patients with myocardial infarction (MI) and maintained or moderately decreased left ventricular ejection fraction: 108 males and 38 females with a mean age of 57 (51; 64) years. The control group was composed of Kemerovo city residents without acute MI (n=300, 190 females and 110 males). To make the evaluation, genomic DNA was isolated from the peripheral blood by phenol- chloroform extraction according to the standard protocol. Real-time PCR method was used for genotyping. To conduct the study, 24 polymorphic variants of 14 genes (those of the natriuretic peptides, antioxidant defense systems and the endothelial function) were selected. Results: significant associations with the allelic variants of CBR1 and CBR3 genes (carbonyl reductase 1 and 3 genes) of the antioxidant defense system were found in the sample of studied patients with MI (not divided by gender or age). When the patients were divided by gender, the following associations were found: in males the single-nucleotide polymorphic variant (SNPV) genotypes CBR1 rs9024 and CBR3 rs1056892 had the protective effect against susceptibility to myocardial infarction (dominant inheritance pattern). It was demonstrated that allelic variants in the NPR2 gene (the gene of atrial natriuretic peptide receptor 2) comprised a risk factor for MI development. In females, a relationship between the assessed genetic factors and the MI development (dominant inheritance pattern) could be associated with SNPV genotypes NPR2 rs13288085 and rs7034957, CBR1 rs9024, and CBR3 rs1056892 which are characterized by the protective effect. Conclusion: some polymorphic variants of the genes of the natriuretic peptide and antioxidant defense systems are associated with the risk and the protective effect against MI susceptibility. The preliminary findings indicate that it is necessary to continue investigations of the identified single-nucleotide polymorphic variants and to assess their impact on the MI severity and the risk of recurrent cardiovascular events in the long-term perspective. KEYWORDS: myocardial infarction, gene, natriuretic peptides, antioxidant defense, polymorphic variants. FOR CITATION: Khutornaya M.V., Khryachkova O.N., Sinitskaya A.V. et al. Role of the genes of the natriuretic peptide and antioxidant defense systems in creating the risk of myocardial infarction development (the preliminary results of a pilot study). Russian Medical Inquiry. 2023;7(1):5–12 (in Russ.). DOI: 10.32364/2587-6821-2023-7-1-5-12.","PeriodicalId":21378,"journal":{"name":"Russian Medical Inquiry","volume":"45 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84002149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Issues concerning early diagnosis and timely correction of respiratory disorders in amyotrophic lateral sclerosis (literature review) 肌萎缩性侧索硬化症呼吸系统疾病早期诊断及及时纠正的问题(文献复习)
Pub Date : 2023-01-01 DOI: 10.32364/2587-6821-2023-7-8-4
É. Ermilov, N. V. Isaeva
Amyotrophic lateral sclerosis (ALS) is a rare severe progressive neurodegenerative disease with upper and lower motor neuron lesions, manifested by weakness of somatic muscle tissue with disorder of vital functions and leading to early disability and fatal outcome of patients. Regardless of the disease form, patients with ALS experience breathing and swallowing disorders. Hypercapnic respiratory failure (HRF) most commonly develop in patients as a consequence of respiratory muscle weakness. Instrumental diagnostic methods are currently used along with the assessment of the HRF clinical picture in ALS. Pulse oximetry and spirometry are the basic means of assessing the respiratory system function. Cardio-respiratory monitoring and arterial blood gas test play an auxiliary role in the diagnosis. To correct respiratory disorders, respiratory support is used with the help of artificial ventilation devices connected through various masks (non-invasive) or through a tracheostomy (invasive). In recent years, it has been proven that early diagnosis and correction of respiratory disorders contribute to prolonging the life of patients with ALS and improving its quality. The review presents the main development mechanisms of respiratory disorders in ALS, clinical and instrumental methods of their diagnosis, methods of correction, as well as criteria for the start of respiratory support. KEYWORDS: amyotrophic lateral sclerosis, respiratory disorders, lung ventilation, pulmonary support, neurodegeneration, NIV, ALV. FOR CITATION: Ermilov E.A., Isaeva N.V. Issues concerning early diagnosis and timely correction of respiratory disorders in amyotrophic lateral sclerosis (literature review). Russian Medical Inquiry. 2023;7(8). (in Russ.). DOI: 10.32364/2587-6821-2023-7-8-4.
肌萎缩性侧索硬化症(Amyotrophic lateral sclerosis, ALS)是一种罕见的严重进行性神经退行性疾病,以上下运动神经元病变为特征,表现为躯体肌肉组织无力,重要功能紊乱,可导致患者早期残疾和死亡。无论疾病形式如何,ALS患者都会出现呼吸和吞咽障碍。高碳酸血症性呼吸衰竭(HRF)最常在患者中发展为呼吸肌肉无力的结果。仪器诊断方法目前与评估HRF临床图像一起用于ALS。脉搏血氧仪和肺活量仪是评估呼吸系统功能的基本手段。心肺监护和动脉血气检查在诊断中起辅助作用。为了纠正呼吸系统疾病,通过各种口罩(非侵入性)或气管切开术(侵入性)连接人工通气装置来使用呼吸支持。近年来,呼吸系统疾病的早期诊断和纠正有助于延长ALS患者的生命,提高患者的生命质量。本文综述了ALS患者呼吸系统疾病的主要发生机制、临床和仪器诊断方法、纠正方法以及开始呼吸支持的标准。关键词:肌萎缩侧索硬化症,呼吸系统疾病,肺通气,肺支持,神经变性,NIV, ALV。引用本文:Ermilov E.A, Isaeva N.V.关于肌萎缩侧索硬化症呼吸系统疾病早期诊断和及时纠正的问题(文献综述)。俄罗斯医学调查。2023;7(8)。(俄国人)。DOI: 10.32364 / 2587-6821-2023-7-8-4。
{"title":"Issues concerning early diagnosis and timely correction of respiratory disorders in amyotrophic lateral sclerosis (literature review)","authors":"É. Ermilov, N. V. Isaeva","doi":"10.32364/2587-6821-2023-7-8-4","DOIUrl":"https://doi.org/10.32364/2587-6821-2023-7-8-4","url":null,"abstract":"Amyotrophic lateral sclerosis (ALS) is a rare severe progressive neurodegenerative disease with upper and lower motor neuron lesions, manifested by weakness of somatic muscle tissue with disorder of vital functions and leading to early disability and fatal outcome of patients. Regardless of the disease form, patients with ALS experience breathing and swallowing disorders. Hypercapnic respiratory failure (HRF) most commonly develop in patients as a consequence of respiratory muscle weakness. Instrumental diagnostic methods are currently used along with the assessment of the HRF clinical picture in ALS. Pulse oximetry and spirometry are the basic means of assessing the respiratory system function. Cardio-respiratory monitoring and arterial blood gas test play an auxiliary role in the diagnosis. To correct respiratory disorders, respiratory support is used with the help of artificial ventilation devices connected through various masks (non-invasive) or through a tracheostomy (invasive). In recent years, it has been proven that early diagnosis and correction of respiratory disorders contribute to prolonging the life of patients with ALS and improving its quality. The review presents the main development mechanisms of respiratory disorders in ALS, clinical and instrumental methods of their diagnosis, methods of correction, as well as criteria for the start of respiratory support. KEYWORDS: amyotrophic lateral sclerosis, respiratory disorders, lung ventilation, pulmonary support, neurodegeneration, NIV, ALV. FOR CITATION: Ermilov E.A., Isaeva N.V. Issues concerning early diagnosis and timely correction of respiratory disorders in amyotrophic lateral sclerosis (literature review). Russian Medical Inquiry. 2023;7(8). (in Russ.). DOI: 10.32364/2587-6821-2023-7-8-4.","PeriodicalId":21378,"journal":{"name":"Russian Medical Inquiry","volume":"209 4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73022551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Russian Medical Inquiry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1